Senator Bernie Sanders tager kampen op mod Novo Nordisk over priserne på vægttabsmedicin. Hvem snapper sejren?
I en bemærkelsesværdig høring i den amerikanske senat konfronterer senator Bernie Sanders Novo Nordisk's administrerende direktør, Lars Fruergaard Jørgensen, angående de skandaløst høje priser for virksomhedens populære vægttabsprodukter, Ozempic og Wegovy. Sanders, der er kendt for sin skarpe kritik af medicinalindustrien, stiller spørgsmål ved, hvorfor amerikanere betaler næsten det dobbelte for de samme medikamenter sammenlignet med patienter i andre lande. Dette har ført til en intensiv debat om prisregulering og tilgængelighed af livsvigtige mediciner i USA.
Sagen er særlig interessant, fordi Novo Nordisk's vægttabsprodukter har oplevet en eksplosiv efterspørgsel, men dette kommer ikke uden konsekvenser for både patienter og det offentlige sundhedsvæsen. Ifølge Sanders har de høje priser direkte indflydelse på forsikringspræmier og offentlige sundhedsprogrammer, hvilket gør denne diskussion endnu mere relevant for den bredere befolkning. Senatets høring lover at bringe flere fordele for patienter, særligt når det kommer til at presse Novo Nordisk til at overveje deres prisstrategi.
Udover Sanders’ pres, står Novo Nordisk overfor et sundhedssystem, der i stigende grad er kritisk over for prissætningen af medicin. Under høringen vil Jørgensen skulle forsvare sin virksomhed mod anklager om, at de ikke blot driver forretning, men også sætter profit over patienternes behov. Det er en kamp mod tiden for selskabet, der ønsker at aflevere en troværdig forklaring på, hvordan de håndterer lægemiddelomkostninger i lyset af offentlighedens voksende utilfredshed.
Lyset ville dog ikke blot være at kaste mod Novo Nordisk. Tallene taler for sig selv: En rapport viser, at patienterne i USA betaler tre gange mere for insuliner end i de fleste europæiske lande. Samtidig er Novo Nordisk's medicin blevet en livredder for millioner med type 2-diabetes og svær overvægt. Med dette i tankerne er kampen om pris og tilgængelighed ikke blot en juridisk strid, men en vital diskussion om liv og død for mange amerikanere. Gør dig klar til et showdown, der kan ændre ansigtet på medicinpriserne i USA!
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview. Novo Nordisk has faced pressure from Bernie Sanders over its pricing ...
U.S. Senator Bernie Sanders is set to question Novo Nordisk CEO Lars Jorgensen on Tuesday over the drugmaker's prices for its popular weight-loss and ...
Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is scheduled to testify on Capitol ...
High U.S. prices and demand for Ozempic and Wegovy have implications for insurance premiums, public program costs, and affordability.
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.
Sen. Bernie Sanders (I-VT) is set to question Novo Nordisk CEO Lars Jorgensen on Tuesday over the drugmaker's prices for its popular weight-loss and ...
Novo Nordisk CEO will defend the prices of his company's mega-blockbuster obesity and Type 2 diabetes medicines Tuesday on Capitol Hill.
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, is set to grill Novo Nordisk CEO Lars Jorgenson ...
WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo Nordisk's Ozempic and Wegovy ...
Sen. Bernard Sanders scolded a Danish drugmaker Tuesday for charging Americans at least six times what other nations pay for "game-changing" weight-loss ...
Novo Nordisk CEO has cautioned that reducing drugs' list prices can carry harmful unintended consequences for patients' ability to obtain them.
Sen. Bernie Sanders is seen pointing and speaking at the opening of a Senate committee. Senator Bernie Sanders accused the drugmaker of prioritizing profits ...
Sen. Bernie Sanders (I-Vt.) has once again criticized Novo Nordisk A/S (NYSE:NVO) for the high price of its diabetes drug, Ozempic, in the United States.
SAN ANTONIO - U.S. Senator Bernie Sanders and U.S. Rep. Greg Casar (D-Texas) are set to rally supporters along the Interstate 35 corridor to boost voter registration and galvanize the working class ahead of the 2024 election.
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for brand-name prescriptions.
Sanders, a Vermont independent, has twice sought the Democratic presidential nomination, forcing discussions of economic justice into the political mainstream.
WASHINGTON, Sept. 24 – As millions of Americans struggle with diabetes and obesity, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, ...
Three major Pharmaceutical Benefit Managers (PBMs) confirmed that lower list prices would make the blockbuster drugs more widely available.
The CEO of Novo Nordisk took questions for more than two hours during a Senate Health Committee hearing focused on addressing the high cost Ozempic and ...
While grilling Novo Nordisk's chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen.
Tesla CEO Elon Musk attends the 10th Annual Breakthrough Prize Ceremony at Academy Museum of Motion. “I really am with Bernie on this one,” Musk said, siding ...
The CEO of Novo Nordisk took questions for more than two hours during a Senate Health Committee hearing focused on addressing the high cost Ozempic and ...
Despite pressure from Bernie Sanders, Novo Nordisk CEO Lars Fruergaard Jørgensen wouldn't commit to lowering Ozempic and Wegovy prices during a Senate ...
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.
Lars Fruergaard Jørgensen was well prepared for Tuesday's Senate hearing. But there was new information he had to deal with.
U.S. Sen. Bernie Sanders has been touring the state embarking on his first ever “Basketball with Bernie” events for youth.
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.. Local Mississippi Breaking News Story ...
The senator and the Tesla CEO agree on the need to make diabetes and weight loss drugs like Ozempic more affordable for Americans.
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.